Your browser is no longer supported. Please, upgrade your browser.
MMM 3M Company daily Stock Chart
MMM [NYSE]
3M Company
IndexDJIA S&P500 P/E18.55 EPS (ttm)8.52 Insider Own0.10% Shs Outstand576.80M Perf Week3.66%
Market Cap90.01B Forward P/E17.68 EPS next Y8.94 Insider Trans-10.75% Shs Float574.05M Perf Month-2.74%
Income4.97B PEG13.17 EPS next Q1.77 Inst Own68.10% Short Float1.06% Perf Quarter18.17%
Sales32.35B P/S2.78 EPS this Y-14.90% Inst Trans-2.98% Short Ratio1.66 Perf Half Y-11.40%
Book/sh17.59 P/B8.99 EPS next Y10.08% ROA11.50% Target Price156.87 Perf Year-8.08%
Cash/sh7.86 P/C20.10 EPS next 5Y1.41% ROE48.50% 52W Range114.04 - 187.72 Perf YTD-10.38%
Dividend5.88 P/FCF39.79 EPS past 5Y0.90% ROI16.30% 52W High-15.78% Beta0.99
Dividend %3.72% Quick Ratio1.20 Sales past 5Y0.20% Gross Margin47.60% 52W Low38.64% ATR4.10
Employees96163 Current Ratio1.70 Sales Q/Q2.70% Oper. Margin20.50% RSI (14)53.89 Volatility1.74% 2.61%
OptionableYes Debt/Eq2.22 EPS Q/Q46.80% Profit Margin15.40% Rel Volume0.57 Prev Close157.04
ShortableYes LT Debt/Eq1.90 EarningsJul 28 BMO Payout67.20% Avg Volume3.68M Price158.10
Recom3.20 SMA20-0.07% SMA503.23% SMA200-0.48% Volume2,096,878 Change0.67%
Mar-30-20Downgrade Gordon Haskett Hold → Underperform
Jan-09-20Upgrade Wolfe Research Underperform → Peer Perform
Dec-23-19Upgrade JP Morgan Underweight → Neutral $143 → $150
Dec-12-19Downgrade UBS Neutral → Sell $180 → $160
Dec-09-19Downgrade Citigroup Buy → Neutral $180
Oct-03-19Reiterated Barclays Underweight $162 → $158
Jul-12-19Reiterated UBS Neutral $201 → $182
Jul-09-19Downgrade RBC Capital Mkts Outperform → Sector Perform $207 → $176
Apr-29-19Downgrade Gordon Haskett Buy → Hold
Apr-26-19Initiated Argus Hold
Apr-26-19Downgrade BofA/Merrill Buy → Neutral
Oct-12-18Initiated Gordon Haskett Buy
Oct-12-18Initiated Credit Suisse Outperform
Aug-21-18Initiated Morgan Stanley Equal-Weight $212
May-16-18Downgrade Jefferies Buy → Hold
May-03-18Upgrade RBC Capital Mkts Sector Perform → Outperform $238
Apr-03-18Reiterated Stifel Hold $251 → $225
Feb-15-18Initiated Barclays Underweight $235
Feb-13-18Upgrade Deutsche Bank Hold → Buy $240 → $275
Jan-24-18Upgrade Hilliard Lyons Neutral → Buy
Jul-06-20 01:11PM  
10:52AM  
Jul-01-20 11:11AM  
Jun-30-20 03:41PM  
Jun-29-20 11:55AM  
Jun-23-20 02:07PM  
09:35AM  
Jun-17-20 06:00AM  
Jun-16-20 08:34AM  
Jun-15-20 03:18PM  
03:17PM  
03:00PM  
10:10AM  
09:51AM  
09:45AM  
09:21AM  
06:43AM  
06:30AM  
Jun-11-20 07:15AM  
Jun-09-20 10:30AM  
08:20AM  
01:28AM  
Jun-08-20 06:00PM  
03:30PM  
02:56PM  
Jun-05-20 11:34AM  
Jun-03-20 03:55PM  
09:43AM  
06:40AM  
06:38AM  
06:30AM  
Jun-02-20 11:31AM  
08:03AM  
May-30-20 12:10PM  
07:32AM  
May-29-20 07:54PM  
May-28-20 11:31AM  
11:02AM  
May-26-20 12:53PM  
May-23-20 07:00AM  
May-22-20 05:30PM  
May-21-20 12:41PM  
11:46AM  
10:46AM  
May-19-20 11:16AM  
May-18-20 05:01PM  
03:37PM  
May-16-20 07:17AM  
May-15-20 04:59PM  
11:39AM  
06:40AM  
May-14-20 12:46PM  
12:37PM  
11:46AM  
11:18AM  
11:09AM  
08:04AM  
07:30AM  
06:42AM  
06:30AM  
May-13-20 05:00PM  
06:47AM  
May-12-20 05:55PM  
04:53PM  
03:18PM  
02:11PM  
01:45PM  
May-11-20 02:52PM  
May-08-20 03:29PM  
May-07-20 03:04PM  
11:15AM  
May-06-20 01:40PM  
10:03AM  
May-05-20 06:01PM  
01:28PM  
12:37PM  
09:07AM  
May-04-20 11:20AM  
May-03-20 10:22AM  
May-02-20 02:17PM  
May-01-20 04:30PM  
01:46PM  
10:27AM  
08:23AM  
07:18AM  
Apr-30-20 03:04PM  
Apr-29-20 01:50PM  
08:47AM  
07:12AM  
Apr-28-20 09:27PM  
08:15PM  
04:56PM  
04:46PM  
04:09PM  
04:08PM  
03:49PM  
11:19AM  
10:46AM  
10:46AM  
10:28AM  
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shafer Stephen MSenior Vice PresidentJun 01Option Exercise155.581,298201,9433,438Jun 03 01:27 PM
Vale Michael G.Executive Vice PresidentMay 08Option Exercise89.477,812698,94054,712May 11 10:54 AM
Vale Michael G.Executive Vice PresidentMay 08Sale148.3414,0622,085,98846,900May 11 10:54 AM
Hammes Eric D.Executive Vice PresidentMay 06Option Exercise89.471,02691,79610,827May 07 10:52 AM
Hammes Eric D.Executive Vice PresidentMay 06Sale146.361,026150,1659,801May 07 10:52 AM
Keel Paul AExecutive Vice PresidentMay 05Option Exercise89.478,249738,03825,080May 06 10:04 AM
Keel Paul AExecutive Vice PresidentMay 05Sale147.1710,2491,508,29716,831May 06 10:04 AM
Ashish Khandpur KExecutive Vice PresidentMay 04Option Exercise89.473,605322,53919,193May 05 11:29 AM
Silberhorn Ty RSenior Vice PresidentMay 04Option Exercise101.4914,6231,484,08816,571May 05 11:35 AM
Silberhorn Ty RSenior Vice PresidentMay 04Sale146.4614,6232,141,6851,948May 05 11:35 AM
Ashish Khandpur KExecutive Vice PresidentMay 04Sale146.853,605529,39915,588May 05 11:29 AM
Roman Michael FChairman, President & CEOMay 01Option Exercise89.4710,067900,69457,868May 04 04:36 PM
Roman Michael FChairman, President & CEOMay 01Sale148.707,8941,173,82749,974May 04 04:36 PM
Silberhorn Ty RSenior Vice PresidentFeb 21Option Exercise101.491,967199,6313,849Feb 24 10:33 AM
Silberhorn Ty RSenior Vice PresidentFeb 21Sale158.191,967311,1601,882Feb 24 10:33 AM
Vale Michael G.Executive Vice PresidentFeb 18Sale159.176,250994,80352,604Feb 19 01:11 PM
Reinseth Theresa EVice President/CAOFeb 07Option Exercise160.0839463,0721,315Feb 10 10:06 AM
Roman Michael FChairman, President & CEOJan 31Option Exercise78.728,906701,08048,152Feb 03 02:52 PM
Roman Michael FChairman, President & CEOJan 31Sale162.008,9061,442,77239,246Feb 03 02:52 PM
Bushman Julie LExecutive Vice PresidentDec 02Sale170.166,8791,170,53133,652Dec 03 02:50 PM
Bushman Julie LExecutive Vice PresidentNov 29Option Exercise169.7712,6462,146,91146,298Dec 03 02:50 PM
Roman Michael FChairman, President & CEONov 29Option Exercise169.7712,6462,146,91145,288Dec 02 05:56 PM
Vale Michael G.Executive Vice PresidentNov 29Option Exercise169.7712,6462,146,91156,456Dec 02 04:44 PM
Silberhorn Ty RSenior Vice PresidentNov 13Option Exercise87.891,634143,6121,967Nov 14 12:25 PM
Silberhorn Ty RSenior Vice PresidentNov 13Sale170.721,634278,950333Nov 14 12:25 PM
Ashish Khandpur KExecutive Vice PresidentNov 05Option Exercise78.723,362264,65713,988Nov 06 11:06 AM
Hammes Eric D.Senior Vice PresidentNov 05Option Exercise78.721,341105,5648,520Nov 06 10:49 AM
Hammes Eric D.Senior Vice PresidentNov 05Sale174.251,341233,6697,179Nov 06 10:49 AM
Ashish Khandpur KExecutive Vice PresidentNov 05Sale174.203,362585,65110,626Nov 06 11:06 AM
Banovetz John PatrickSr Vice PresidentAug 02Option Exercise78.721,04081,8695,974Aug 05 02:51 PM
Banovetz John PatrickSr Vice PresidentAug 02Sale170.401,040177,2134,934Aug 05 02:51 PM
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E46.65 EPS (ttm)1.99 Insider Own0.70% Shs Outstand1.77B Perf Week4.80%
Market Cap163.40B Forward P/E25.28 EPS next Y3.68 Insider Trans-6.02% Shs Float1.76B Perf Month5.35%
Income3.55B PEG4.54 EPS next Q0.41 Inst Own76.30% Short Float0.73% Perf Quarter17.02%
Sales32.10B P/S5.09 EPS this Y45.20% Inst Trans-0.34% Short Ratio1.60 Perf Half Y8.24%
Book/sh17.08 P/B5.44 EPS next Y29.64% ROA5.30% Target Price101.93 Perf Year8.84%
Cash/sh2.09 P/C44.55 EPS next 5Y10.28% ROE11.50% 52W Range61.61 - 100.00 Perf YTD7.03%
Dividend1.44 P/FCF76.60 EPS past 5Y12.40% ROI8.20% 52W High-7.03% Beta0.96
Dividend %1.55% Quick Ratio1.00 Sales past 5Y9.50% Gross Margin58.50% 52W Low50.90% ATR2.52
Employees107000 Current Ratio1.40 Sales Q/Q2.50% Oper. Margin14.00% RSI (14)56.54 Volatility2.07% 2.80%
OptionableYes Debt/Eq0.60 EPS Q/Q-8.60% Profit Margin11.20% Rel Volume0.70 Prev Close92.23
ShortableYes LT Debt/Eq0.56 EarningsJul 16 BMO Payout65.30% Avg Volume8.03M Price92.97
Recom1.90 SMA203.05% SMA501.91% SMA2008.37% Volume5,604,450 Change0.80%
Jun-01-20Downgrade Goldman Neutral → Sell $84
Mar-05-20Initiated Citigroup Buy $96
Feb-13-20Initiated Goldman Neutral $96
Feb-06-20Resumed BTIG Research Neutral
Jan-02-20Downgrade Guggenheim Buy → Neutral
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Oct-06-17Resumed JP Morgan Neutral
Jul-06-20 04:03PM  
07:30AM  
06:31AM  
Jul-04-20 07:32AM  
Jul-02-20 10:31PM  
05:45PM  
05:17PM  
Jun-30-20 05:56PM  
02:31PM  
11:52AM  
Jun-29-20 09:13AM  
09:00AM  
07:47AM  
Jun-26-20 05:45PM  
09:00AM  
Jun-25-20 11:06AM  
10:00AM  
Jun-24-20 05:50PM  
03:49PM  
12:23PM  
Jun-23-20 05:32PM  
09:00AM  
07:19AM  
Jun-22-20 09:15AM  
Jun-18-20 05:45PM  
Jun-17-20 06:18PM  
07:11AM  
Jun-16-20 12:34PM  
09:00AM  
09:00AM  
07:00AM  
12:00AM  
Jun-15-20 05:18PM  
01:07PM  
11:59AM  
10:49AM  
10:25AM  
07:59AM  
07:17AM  
07:01AM  
Jun-14-20 06:55AM  
Jun-13-20 11:00AM  
Jun-12-20 05:45PM  
10:28AM  
08:58AM  
Jun-11-20 07:09AM  
06:30AM  
02:00AM  
Jun-09-20 10:13AM  
Jun-07-20 11:22AM  
Jun-06-20 07:41AM  
05:52AM  
Jun-05-20 09:21AM  
Jun-04-20 06:50PM  
11:44AM  
Jun-03-20 12:51PM  
Jun-02-20 05:45PM  
02:05PM  
Jun-01-20 07:07PM  
May-30-20 07:44AM  
May-29-20 06:07PM  
May-28-20 07:01AM  
May-27-20 05:45PM  
May-26-20 11:34PM  
03:23PM  
May-24-20 07:33AM  
06:32AM  
May-22-20 06:11PM  
05:37PM  
12:29PM  
09:45AM  
08:40AM  
07:50AM  
May-21-20 05:45PM  
05:44PM  
04:11PM  
03:18PM  
02:18PM  
12:14PM  
07:00AM  
May-19-20 04:05PM  
07:12AM  
May-18-20 06:16AM  
May-16-20 03:10PM  
11:50AM  
11:48AM  
11:30AM  
May-15-20 06:00PM  
05:56PM  
04:54PM  
04:34PM  
04:00PM  
03:46PM  
03:43PM  
02:23PM  
01:43PM  
01:24PM  
11:48AM  
11:32AM  
11:12AM  
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems for infectious diseases; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Earnhardt Lisa DExecutive Vice PresidentJun 10Sale90.8487279,21672,074Jun 12 05:07 PM
LANE ANDREW HExecutive Vice PresidentMay 05Option Exercise43.8280,0003,505,314145,822May 07 05:02 PM
LANE ANDREW HExecutive Vice PresidentMay 05Sale92.0080,0007,360,10465,822May 07 05:02 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentApr 28Sale93.183,724347,01248,767Apr 30 06:34 PM
CAPEK JOHN MExecutive Vice PresidentApr 21Option Exercise22.3950,1001,121,834366,900Apr 23 09:34 PM
Ginascol John FExecutive Vice PresidentApr 21Option Exercise38.4063,2002,426,880129,645Apr 23 09:41 PM
Funck Robert EExecutive Vice President & CFOApr 21Option Exercise36.4236,7001,336,638206,072Apr 23 09:27 PM
Contreras JaimeSenior Vice PresidentApr 21Option Exercise57.12108,4126,192,995145,431Apr 23 09:26 PM
Scoggins Christopher JSenior Vice PresidentApr 21Sale96.1041439,78539,706Apr 23 09:28 PM
Ginascol John FExecutive Vice PresidentApr 21Sale96.0063,2006,067,05166,445Apr 23 09:41 PM
CAPEK JOHN MExecutive Vice PresidentApr 21Sale95.8750,1004,803,326316,800Apr 23 09:34 PM
Boudreau Philip PVice PresidentMar 13Sale82.0010,600869,20022,463Mar 16 06:47 PM
Watkin JaredSenior Vice PresidentMar 06Sale82.008,248676,33668,696Mar 10 05:06 PM
Funck Robert EExecutive Vice President & CFOMar 02Sale77.891,356105,619169,372Mar 03 05:28 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentMar 02Sale77.891,420110,60453,859Mar 03 05:27 PM
BIRD ROGERSenior Vice PresidentMar 02Sale77.8966651,87562,920Mar 03 05:23 PM
DALE MICHAEL DSenior Vice PresidentMar 02Sale77.8978761,29934,763Mar 03 05:21 PM
Ginascol John FExecutive Vice PresidentMar 02Sale77.636,606512,80566,445Mar 03 05:20 PM
Contreras JaimeSenior Vice PresidentMar 02Sale77.892,001155,85837,019Mar 03 05:19 PM
Watkin JaredSenior Vice PresidentMar 02Sale77.891,761137,16476,944Mar 03 05:19 PM
ALLEN HUBERT LExecutive Vice PresidentMar 02Sale77.891,20894,091151,896Mar 03 05:16 PM
Scoggins Christopher JSenior Vice PresidentMar 02Sale77.891,24096,58441,168Mar 03 05:15 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 02Sale77.8999977,812103,493Mar 03 05:16 PM
BRYNELSEN CHARLESSenior Vice PresidentMar 02Sale77.891,781138,72245,460Mar 03 05:13 PM
Wainer Andrea FExecutive Vice PresidentMar 02Sale77.891,429111,30549,498Mar 03 05:10 PM
Moreland Mary KExecutive Vice PresidentFeb 25Sale84.9340033,97266,131Feb 25 05:29 PM
Moreland Mary KExecutive Vice PresidentFeb 19Sale88.971,01990,66052,985Feb 19 05:53 PM
DALE MICHAEL DSenior Vice PresidentFeb 19Sale88.9739635,23223,947Feb 19 05:53 PM
Wainer Andrea FExecutive Vice PresidentFeb 07Sale88.611,12099,24540,140Feb 11 06:10 PM
YOOR BRIAN BExecutive Vice President & CFOJan 28Option Exercise45.33509,85023,110,674624,231Jan 30 05:23 PM
YOOR BRIAN BExecutive Vice President & CFOJan 28Sale89.73509,85045,747,209114,381Jan 30 05:23 PM
MANNING JOSEPH JSenior Vice PresidentJan 27Option Exercise38.4037,5001,440,00088,032Jan 29 05:06 PM
MANNING JOSEPH JSenior Vice PresidentJan 27Sale89.5837,5003,359,41150,534Jan 29 05:06 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentOct 23Option Exercise38.4016,000614,40068,562Oct 25 05:02 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentOct 23Sale80.5421,0001,691,31547,562Oct 25 05:02 PM
MANNING JOSEPH JSenior Vice PresidentAug 30Option Exercise47.0047,2262,219,62297,755Sep 04 05:20 PM
MANNING JOSEPH JSenior Vice PresidentAug 30Sale85.1447,2264,020,68550,532Sep 04 05:20 PM
PEDERSON MICHAEL JSenior Vice PresidentAug 09Option Exercise50.7223,0081,166,966104,228Aug 13 07:12 PM
Funck Robert ESenior Vice PresidentAug 09Option Exercise34.9440,0001,397,600178,991Aug 13 07:11 PM
PEDERSON MICHAEL JSenior Vice PresidentAug 09Sale86.3923,0081,987,70581,220Aug 13 07:12 PM
YOOR BRIAN BExecutive Vice President & CFOAug 08Option Exercise38.0343,7631,664,357158,144Aug 09 05:05 PM
YOOR BRIAN BExecutive Vice President & CFOAug 08Sale85.7743,7633,753,706114,381Aug 09 05:05 PM
Blount Sally E.DirectorJul 31Sale87.652,500219,12126,266Aug 02 05:01 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentJul 24Option Exercise38.4065,0002,496,000117,562Jul 26 09:30 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentJul 24Sale88.0165,0005,720,32552,562Jul 26 09:30 PM
ABBV AbbVie Inc. daily Stock Chart
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E17.52 EPS (ttm)5.65 Insider Own0.10% Shs Outstand1.48B Perf Week3.00%
Market Cap174.95B Forward P/E8.43 EPS next Y11.75 Insider Trans-1.99% Shs Float1.47B Perf Month6.42%
Income8.39B PEG1.71 EPS next Q2.13 Inst Own62.90% Short Float1.34% Perf Quarter34.95%
Sales34.06B P/S5.14 EPS this Y42.30% Inst Trans1.31% Short Ratio1.89 Perf Half Y11.62%
Book/sh-5.01 P/B- EPS next Y14.53% ROA11.30% Target Price104.44 Perf Year35.65%
Cash/sh- P/C- EPS next 5Y10.28% ROE-103.70% 52W Range62.55 - 99.99 Perf YTD11.83%
Dividend4.72 P/FCF24.95 EPS past 5Y36.80% ROI21.20% 52W High-0.98% Beta0.82
Dividend %4.77% Quick Ratio3.00 Sales past 5Y10.80% Gross Margin77.10% 52W Low58.29% ATR2.38
Employees30000 Current Ratio3.10 Sales Q/Q10.10% Oper. Margin39.90% RSI (14)65.61 Volatility2.24% 2.59%
OptionableYes Debt/Eq- EPS Q/Q22.50% Profit Margin24.60% Rel Volume0.67 Prev Close98.88
ShortableYes LT Debt/Eq- EarningsMay 01 BMO Payout77.50% Avg Volume10.43M Price99.01
Recom1.90 SMA203.16% SMA508.61% SMA20016.50% Volume7,035,650 Change0.13%
Jun-23-20Upgrade Atlantic Equities Neutral → Overweight $115
Jun-09-20Upgrade Wolfe Research Peer Perform → Outperform
Jun-02-20Upgrade Argus Hold → Buy $115
May-18-20Resumed BofA/Merrill Neutral $95
May-12-20Upgrade JP Morgan Neutral → Overweight $105
May-11-20Resumed Morgan Stanley Overweight $95
Apr-20-20Upgrade RBC Capital Mkts Sector Perform → Outperform $79 → $93
Mar-23-20Downgrade Societe Generale Buy → Hold
Feb-27-20Initiated Barclays Equal Weight $97
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Sector Perform $86
Dec-26-19Reiterated Cowen Outperform $90 → $98
Sep-26-19Upgrade Citigroup Neutral → Buy $87 → $90
Aug-20-19Upgrade Piper Jaffray Neutral → Overweight $80
Jun-27-19Upgrade Wolfe Research Underperform → Peer Perform
Jun-26-19Upgrade SVB Leerink Mkt Perform → Outperform $88
May-28-19Initiated Goldman Neutral
Apr-29-19Upgrade BMO Capital Markets Underperform → Market Perform
Mar-25-19Downgrade Argus Buy → Hold
Jan-23-19Initiated UBS Neutral $91
Jul-06-20 09:59AM  
Jul-05-20 07:04AM  
Jul-03-20 09:15AM  
08:07AM  
07:00AM  
Jul-02-20 05:35PM  
12:32PM  
08:37AM  
Jul-01-20 02:08PM  
12:00PM  
09:33AM  
09:29AM  
Jun-30-20 02:35PM  
12:12PM  
09:52AM  
Jun-29-20 08:05AM  
Jun-26-20 11:45AM  
08:28AM  
08:25AM  
08:21AM  
01:15AM  
Jun-25-20 12:17PM  
09:00AM  
03:41AM  
Jun-24-20 01:43PM  
11:05AM  
09:12AM  
Jun-23-20 12:20PM  
11:33AM  
07:30AM  
Jun-22-20 12:18PM  
11:30AM  
11:30AM  
08:00AM  
Jun-19-20 07:00PM  
12:23PM  
12:08PM  
11:58AM  
11:50AM  
11:27AM  
07:41AM  
07:25AM  
Jun-18-20 10:31AM  
08:45AM  
08:00AM  
Jun-17-20 10:32AM  
07:00AM  
06:07AM  
Jun-16-20 10:31AM  
Jun-15-20 10:46AM  
09:24AM  
08:15AM  
08:00AM  
Jun-14-20 11:16AM  
07:17AM  
Jun-13-20 06:46AM  
02:30AM  
Jun-12-20 04:45PM  
03:02PM  
10:40AM  
10:23AM  
09:48AM  
09:21AM  
08:53AM  
08:00AM  
Jun-11-20 10:56AM  
10:31AM  
09:15AM  
08:12AM  
07:01AM  
Jun-10-20 05:10PM  
04:02PM  
11:45AM  
11:30AM  
11:26AM  
10:29AM  
10:18AM  
09:50AM  
08:15AM  
07:38AM  
07:30AM  
07:26AM  
06:12AM  
06:00AM  
Jun-09-20 04:28PM  
01:57PM  
12:40PM  
Jun-08-20 05:45PM  
12:29PM  
11:44AM  
11:10AM  
09:11AM  
02:49AM  
Jun-07-20 11:22AM  
06:10AM  
05:29AM  
Jun-06-20 08:51AM  
08:30AM  
Jun-05-20 04:18PM  
12:10PM  
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stewart Jeffrey RyanSVP, US Commercial OperationsMay 12Sale90.0023,0242,072,21152,760May 12 05:44 PM
RICHMOND TIMOTHY J.EVP, Chief HR OfficerMay 05Sale85.0019,4451,652,8250May 07 05:01 PM
Durkin Brian LVP, ControllerMar 30Buy69.0075051,75016,844Mar 20 04:56 PM
Durkin Brian LVP, ControllerMar 20Buy67.5080054,00016,094Mar 20 04:56 PM
Durkin Brian LVP, ControllerMar 18Buy68.182,200150,00515,294Mar 20 04:56 PM
RAPP EDWARD JDirectorMar 03Buy87.872,875252,6172,875Mar 04 05:14 PM
RICHMOND TIMOTHY J.EVP, Chief HR OfficerSep 27Sale75.0215,5151,163,8730Oct 01 05:52 PM
Schumacher Laura JVice ChairmanSep 16Buy70.4225,0001,760,523164,838Sep 18 04:25 PM
Donoghoe NicholasSVP, Enterprise InnovationAug 29Buy66.197,525498,05713,090Aug 30 04:08 PM
Stewart Jeffrey RyanSVP, US Commercial OperationsAug 16Buy64.4415,5521,002,16965,304Aug 20 04:16 PM
AUSTIN ROXANNE SDirectorAug 01Buy65.6625,0001,641,400117,114Aug 02 05:02 PM
AUSTIN ROXANNE SDirectorJul 31Buy66.0230,0001,980,69092,114Aug 02 05:02 PM
AUSTIN ROXANNE SDirectorJul 30Buy66.3510,000663,50062,114Jul 31 04:46 PM
Gosebruch Henry OEVP, Chief Strategy OfficerJul 29Buy67.2830,0002,018,38575,763Jul 31 04:46 PM
AFL Aflac Incorporated daily Stock Chart
AFL [NYSE]
Aflac Incorporated
IndexS&P 500 P/E9.07 EPS (ttm)3.97 Insider Own0.30% Shs Outstand724.37M Perf Week3.86%
Market Cap25.94B Forward P/E8.07 EPS next Y4.47 Insider Trans-1.22% Shs Float655.81M Perf Month-8.42%
Income2.94B PEG5.67 EPS next Q1.06 Inst Own62.90% Short Float1.22% Perf Quarter11.14%
Sales21.84B P/S1.19 EPS this Y16.70% Inst Trans-3.91% Short Ratio1.94 Perf Half Y-32.01%
Book/sh36.45 P/B0.99 EPS next Y3.09% ROA1.90% Target Price41.45 Perf Year-36.60%
Cash/sh5.76 P/C6.25 EPS next 5Y1.60% ROE10.40% 52W Range23.07 - 57.18 Perf YTD-31.91%
Dividend1.12 P/FCF5.70 EPS past 5Y6.40% ROI10.00% 52W High-37.01% Beta0.89
Dividend %3.11% Quick Ratio- Sales past 5Y-0.40% Gross Margin- 52W Low56.13% ATR1.43
Employees10977 Current Ratio- Sales Q/Q-8.80% Oper. Margin19.00% RSI (14)49.10 Volatility3.29% 3.69%
OptionableYes Debt/Eq0.25 EPS Q/Q-36.60% Profit Margin13.50% Rel Volume0.75 Prev Close35.26
ShortableYes LT Debt/Eq0.25 EarningsJul 28 AMC Payout27.30% Avg Volume4.12M Price36.02
Recom3.10 SMA20-2.63% SMA50-0.78% SMA200-20.37% Volume3,094,806 Change2.16%
Mar-20-20Upgrade RBC Capital Mkts Underperform → Sector Perform $46 → $35
Jul-29-19Downgrade Raymond James Strong Buy → Outperform $62
Jul-16-19Downgrade Evercore ISI In-line → Underperform
Jan-02-19Downgrade JP Morgan Overweight → Neutral
Aug-01-18Upgrade Sandler O'Neill Hold → Buy
Apr-25-18Initiated Credit Suisse Neutral $49
Mar-21-18Reiterated Barclays Equal Weight $90 → $45
Jan-22-18Upgrade Raymond James Outperform → Strong Buy
Sep-26-17Downgrade Citigroup Neutral → Sell
Sep-08-17Downgrade BofA/Merrill Neutral → Underperform
Jul-03-17Reiterated Barclays Equal Weight $71 → $73
May-01-17Reiterated RBC Capital Mkts Underperform $62 → $66
Apr-18-17Upgrade Raymond James Mkt Perform → Outperform
Apr-06-17Upgrade BofA/Merrill Underperform → Neutral
Feb-02-17Reiterated RBC Capital Mkts Underperform $65 → $62
Jan-26-17Initiated Citigroup Neutral
Dec-09-16Downgrade RBC Capital Mkts Sector Perform → Underperform $74 → $65
Oct-07-16Initiated Credit Suisse Underperform
Sep-23-16Resumed Wells Fargo Market Perform
May-23-16Downgrade Sandler O'Neill Buy → Hold
Jul-05-20 05:34PM  
Jul-01-20 11:50AM  
Jun-30-20 09:40AM  
Jun-29-20 08:10AM  
Jun-26-20 11:38AM  
Jun-25-20 10:03AM  
08:30AM  
Jun-17-20 02:11PM  
05:00AM  
Jun-16-20 10:36AM  
Jun-12-20 10:36AM  
Jun-10-20 09:00AM  
Jun-05-20 11:34AM  
May-29-20 11:31AM  
May-26-20 08:00AM  
May-15-20 05:28PM  
02:07PM  
May-14-20 11:33AM  
11:04AM  
May-08-20 06:10AM  
May-06-20 11:44AM  
May-01-20 04:03PM  
Apr-30-20 10:31PM  
04:18PM  
11:48AM  
Apr-29-20 05:45PM  
04:15PM  
Apr-28-20 12:37PM  
Apr-23-20 12:12PM  
08:03AM  
Apr-22-20 04:20PM  
12:31PM  
Apr-16-20 10:39AM  
Apr-14-20 04:30PM  
Apr-13-20 12:04PM  
Apr-06-20 04:29PM  
12:00PM  
11:50AM  
11:45AM  
Apr-03-20 10:36AM  
Apr-02-20 12:30PM  
12:10PM  
Mar-31-20 04:02PM  
Mar-23-20 06:25AM  
Mar-20-20 10:26AM  
Mar-19-20 05:30PM  
Mar-13-20 01:36PM  
Mar-12-20 03:00PM  
Mar-09-20 10:05AM  
Mar-08-20 05:27PM  
Mar-06-20 04:06PM  
Mar-05-20 03:33PM  
11:30AM  
Mar-04-20 04:15PM  
06:53AM  
Feb-25-20 08:00AM  
Feb-21-20 05:45AM  
Feb-20-20 04:20PM  
Feb-12-20 12:16AM  
Feb-10-20 11:10AM  
Feb-06-20 03:30PM  
Feb-04-20 06:05PM  
Feb-03-20 09:22AM  
Jan-28-20 04:20PM  
12:31PM  
Jan-24-20 08:44AM  
Jan-21-20 09:42AM  
Jan-10-20 07:55AM  
Jan-09-20 12:10PM  
09:23AM  
Jan-08-20 06:00AM  
06:00AM  
06:00AM  
Dec-27-19 03:31PM  
Dec-23-19 08:00AM  
Dec-13-19 06:44AM  
Dec-10-19 09:47PM  
Dec-09-19 04:30PM  
Dec-05-19 02:47PM  
Dec-04-19 08:33AM  
Dec-03-19 04:15PM  
12:00PM  
08:20AM  
Nov-26-19 09:40AM  
08:33AM  
Nov-25-19 04:15PM  
Nov-22-19 10:01AM  
Nov-21-19 08:38AM  
Nov-20-19 09:41AM  
Nov-19-19 08:35AM  
Nov-14-19 11:54AM  
11:14AM  
10:56AM  
Nov-12-19 09:00PM  
11:00AM  
Nov-11-19 03:07PM  
09:11AM  
06:00AM  
Nov-08-19 07:16PM  
Nov-07-19 04:15PM  
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RIMER BARBARA KDirectorMay 01Option Exercise25.4511,026280,55736,982May 05 04:06 PM
RIMER BARBARA KDirectorMay 01Sale36.2311,026399,50525,956May 05 04:06 PM
Crawford Frederick JohnPresident & COOMar 23Buy26.2925,000657,340247,828Mar 24 10:54 AM
Koide MasatoshiPres., and Rep. DirectorFeb 18Sale51.751,46775,91740,898Feb 19 01:18 PM
LAKE CHARLES D IIChairman and Rep. DirectorFeb 18Sale51.8116,530856,41498,988Feb 19 01:18 PM
LAKE CHARLES D IIChairman and Rep. DirectorFeb 06Sale52.6822,6421,192,88782,458Feb 07 04:29 PM
BEAVER STEVEN KENTSVP, CFO, Aflac USDec 09Sale53.035,660300,15715,013Dec 10 02:45 PM
HOWARD JUNE PSr. Vice PresidentDec 06Option Exercise24.2896023,30960,934Dec 10 02:44 PM
HOWARD JUNE PSr. Vice PresidentDec 06Sale53.2596051,12059,974Dec 10 02:44 PM
Williams Richard JRExecutive V.P.Dec 05Sale52.621,90099,98410,919Dec 06 03:34 PM
TILLMAN AUDREY BExecutive Vice PresidentDec 03Option Exercise23.5324,000564,720123,414Dec 04 04:58 PM
TILLMAN AUDREY BExecutive Vice PresidentDec 03Sale51.8124,0001,243,44599,414Dec 04 04:58 PM
Lloyd KaroleDirectorNov 07Buy54.081,00054,08028,181Nov 08 03:19 PM
Fukuzawa ToshihikoDirectorSep 27Sale52.001,50078,00011,349Oct 01 10:00 AM
HOWARD JUNE PSr. Vice PresidentAug 02Option Exercise24.284,00097,12064,591Aug 06 03:38 PM
HOWARD JUNE PSr. Vice PresidentAug 02Sale52.354,000209,40660,591Aug 06 03:38 PM
Daniels James ToddExec. Vice PresidentJul 29Option Exercise23.534,00094,12024,206Jul 30 11:24 AM
Daniels James ToddExec. Vice PresidentJul 29Sale52.985,552294,16418,654Jul 30 11:24 AM
RIMER BARBARA KDirectorJul 26Option Exercise20.125,660113,85132,448Jul 30 11:24 AM
RIMER BARBARA KDirectorJul 26Sale53.744,728254,08727,720Jul 30 11:24 AM
APD Air Products and Chemicals, Inc. daily Stock Chart
APD [NYSE]
Air Products and Chemicals, Inc.
IndexS&P 500 P/E28.18 EPS (ttm)8.83 Insider Own0.25% Shs Outstand221.20M Perf Week5.46%
Market Cap54.16B Forward P/E25.35 EPS next Y9.82 Insider Trans0.04% Shs Float219.88M Perf Month2.02%
Income1.96B PEG2.93 EPS next Q2.00 Inst Own86.10% Short Float1.12% Perf Quarter33.39%
Sales8.98B P/S6.03 EPS this Y2.90% Inst Trans0.19% Short Ratio2.25 Perf Half Y10.14%
Book/sh51.41 P/B4.84 EPS next Y16.67% ROA10.00% Target Price246.27 Perf Year7.95%
Cash/sh10.20 P/C24.39 EPS next 5Y9.62% ROE17.10% 52W Range167.43 - 257.01 Perf YTD5.92%
Dividend5.36 P/FCF- EPS past 5Y11.30% ROI11.50% 52W High-3.15% Beta0.86
Dividend %2.15% Quick Ratio2.40 Sales past 5Y-3.10% Gross Margin34.20% 52W Low48.67% ATR5.82
Employees17440 Current Ratio2.60 Sales Q/Q1.30% Oper. Margin25.70% RSI (14)63.51 Volatility2.14% 2.43%
OptionableYes Debt/Eq0.29 EPS Q/Q16.30% Profit Margin21.70% Rel Volume1.04 Prev Close247.42
ShortableYes LT Debt/Eq0.29 EarningsJul 23 BMO Payout52.70% Avg Volume1.10M Price248.91
Recom2.20 SMA203.62% SMA505.91% SMA2009.56% Volume1,136,383 Change0.60%
Jun-16-20Downgrade HSBC Securities Buy → Hold $225
Apr-15-20Upgrade Bernstein Mkt Perform → Outperform $246 → $262
Mar-11-20Upgrade Wells Fargo Equal Weight → Overweight $260 → $265
Feb-10-20Upgrade Morgan Stanley Equal-Weight → Overweight $280
Nov-26-19Initiated Berenberg Hold $241
Nov-18-19Initiated Atlantic Equities Neutral
Oct-16-19Initiated Wells Fargo Market Perform
Aug-19-19Downgrade Susquehanna Positive → Neutral
Aug-01-19Downgrade HSBC Securities Buy → Hold $217 → $215
Jul-26-19Reiterated Monness Crespi & Hardt Buy $214 → $254
Jul-18-19Downgrade Bernstein Outperform → Mkt Perform
Jul-12-19Downgrade Seaport Global Securities Buy → Neutral
Jul-11-19Downgrade UBS Buy → Neutral $224 → $240
Apr-25-19Upgrade BofA/Merrill Underperform → Neutral
Apr-25-19Downgrade Vertical Research Buy → Hold
Jan-08-19Downgrade BofA/Merrill Neutral → Underperform
Oct-02-18Initiated Exane BNP Paribas Outperform
Sep-24-18Initiated Bernstein Outperform $202
Feb-09-18Upgrade JP Morgan Neutral → Overweight
Jan-29-18Reiterated Monness Crespi & Hardt Buy $180 → $190
Jul-06-20 01:11PM  
09:07AM  
Jul-05-20 08:00PM  
Jul-02-20 08:30AM  
08:30AM  
Jul-01-20 09:15AM  
Jun-30-20 08:56AM  
08:56AM  
Jun-23-20 02:30PM  
Jun-16-20 03:32PM  
Jun-15-20 01:00PM  
Jun-11-20 06:04AM  
Jun-05-20 03:00PM  
Jun-04-20 11:13AM  
Jun-02-20 02:30PM  
01:33PM  
May-30-20 06:22PM  
May-26-20 04:30PM  
08:05AM  
May-23-20 11:30AM  
May-21-20 04:16PM  
12:45PM  
May-20-20 08:31AM  
06:23AM  
May-19-20 10:10AM  
May-18-20 10:20AM  
01:59AM  
May-15-20 07:00AM  
May-14-20 04:15PM  
12:38PM  
06:42AM  
May-08-20 10:30AM  
May-07-20 06:30AM  
May-03-20 06:10PM  
Apr-29-20 09:00AM  
Apr-28-20 05:00PM  
Apr-27-20 10:23AM  
08:45AM  
Apr-24-20 06:16PM  
Apr-23-20 08:44AM  
07:30AM  
06:00AM  
Apr-22-20 11:30AM  
06:04AM  
Apr-21-20 06:40AM  
Apr-20-20 07:00AM  
07:00AM  
Apr-16-20 12:31PM  
Apr-15-20 07:00AM  
Apr-13-20 10:19AM  
Apr-09-20 08:52AM  
Apr-07-20 06:31AM  
Apr-01-20 12:32PM  
11:45AM  
09:35AM  
Mar-30-20 10:15AM  
07:54AM  
07:00AM  
06:59AM  
Mar-26-20 10:30AM  
08:22AM  
06:12AM  
Mar-25-20 02:00PM  
10:00AM  
Mar-24-20 09:45PM  
09:00AM  
Mar-18-20 06:41AM  
Mar-17-20 10:02AM  
Mar-16-20 11:45AM  
08:27AM  
Mar-13-20 04:35PM  
Mar-12-20 02:30PM  
Mar-11-20 09:52PM  
08:50AM  
Mar-09-20 09:00AM  
Mar-04-20 03:45PM  
Mar-01-20 08:42AM  
Feb-28-20 11:45AM  
08:00AM  
Feb-27-20 03:26PM  
10:42AM  
Feb-25-20 09:09AM  
Feb-24-20 02:01PM  
08:42AM  
Feb-23-20 11:30AM  
Feb-20-20 02:30PM  
Feb-19-20 08:51AM  
Feb-13-20 11:11AM  
Feb-12-20 01:30PM  
09:54AM  
Feb-06-20 10:09AM  
Feb-04-20 09:55AM  
Feb-03-20 11:50AM  
06:31AM  
Jan-31-20 03:00PM  
10:15AM  
Jan-30-20 01:22PM  
10:32AM  
Jan-28-20 04:47PM  
05:11AM  
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide. The company produces atmospheric gases, including oxygen, nitrogen, argon, and rare gases; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas, and specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, gasification, metals, electronics, manufacturing, food and beverage, magnetic resonance imaging, energy production and refining, and metals. It also designs and manufactures equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and liquid helium and liquid hydrogen transport and storage. Air Products and Chemicals, Inc. was founded in 1940 and is headquartered in Allentown, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MONSER EDWARD LDirectorJan 29Buy237.6020047,519200Jan 29 02:49 PM
Flugel Russell AVP, Controller and PAONov 29Option Exercise78.063,647284,68510,034Dec 03 03:52 PM
Crocco Michael SExecutive VP and CFONov 29Option Exercise78.064,443346,82152,320Dec 03 03:10 PM
Ghasemi SeifiChairman, Pres. and CEOJul 26Buy227.1620,0004,543,200453,783Jul 26 11:48 AM
ADM Archer-Daniels-Midland Company daily Stock Chart
ADM [NYSE]
Archer-Daniels-Midland Company
IndexS&P 500 P/E14.36 EPS (ttm)2.76 Insider Own0.40% Shs Outstand563.00M Perf Week1.90%
Market Cap21.95B Forward P/E12.02 EPS next Y3.30 Insider Trans-0.93% Shs Float553.10M Perf Month-3.57%
Income1.56B PEG- EPS next Q0.50 Inst Own79.60% Short Float2.00% Perf Quarter14.49%
Sales64.32B P/S0.34 EPS this Y-19.90% Inst Trans-2.08% Short Ratio3.67 Perf Half Y-13.80%
Book/sh33.66 P/B1.18 EPS next Y17.86% ROA3.50% Target Price47.22 Perf Year-5.41%
Cash/sh- P/C- EPS next 5Y-8.80% ROE8.10% 52W Range28.92 - 47.20 Perf YTD-14.41%
Dividend1.44 P/FCF- EPS past 5Y-6.00% ROI4.20% 52W High-15.95% Beta0.95
Dividend %3.63% Quick Ratio1.00 Sales past 5Y-4.50% Gross Margin6.50% 52W Low37.17% ATR1.07
Employees38100 Current Ratio1.50 Sales Q/Q-2.20% Oper. Margin2.10% RSI (14)52.86 Volatility2.07% 2.53%
OptionableYes Debt/Eq0.66 EPS Q/Q57.00% Profit Margin2.40% Rel Volume0.65 Prev Close39.56
ShortableYes LT Debt/Eq0.45 EarningsApr 29 AMC Payout51.60% Avg Volume3.01M Price39.67
Recom2.10 SMA20-1.49% SMA504.39% SMA200-1.67% Volume1,959,678 Change0.28%
Jun-30-20Initiated Barclays Overweight $52
Mar-31-20Reiterated Robert W. Baird Outperform $38 → $41
Mar-02-20Upgrade Monness Crespi & Hardt Sell → Neutral
Jan-09-20Downgrade Monness Crespi & Hardt Neutral → Sell $38
Oct-08-19Initiated Stephens Overweight
Apr-29-19Upgrade BMO Capital Markets Market Perform → Outperform $50 → $51
Feb-08-19Upgrade Stifel Hold → Buy
Nov-08-18Upgrade Argus Hold → Buy
Jul-09-18Upgrade JP Morgan Underweight → Neutral $42 → $48
May-02-18Upgrade Monness Crespi & Hardt Sell → Neutral
Mar-12-18Upgrade Goldman Neutral → Buy
Mar-06-18Upgrade Citigroup Neutral → Buy
Feb-28-18Upgrade Buckingham Research Neutral → Buy
Jan-22-18Reiterated Stifel Hold $44 → $43
Nov-01-17Reiterated Monness Crespi & Hardt Sell $38 → $37
Oct-24-17Initiated Monness Crespi & Hardt Sell $38
Sep-28-17Downgrade Citigroup Buy → Neutral
Jun-01-17Downgrade Argus Buy → Hold
Jan-06-17Downgrade BMO Capital Markets Outperform → Market Perform $51 → $48
Dec-15-16Resumed Stifel Hold $46
Jun-26-20 03:35PM  
Jun-24-20 04:21PM  
Jun-19-20 08:33AM  
Jun-17-20 04:14AM  
Jun-16-20 08:30AM  
Jun-05-20 12:22PM  
11:57AM  
Jun-03-20 04:00PM  
May-29-20 11:31AM  
May-28-20 01:40PM  
11:39AM  
May-27-20 08:18AM  
08:00AM  
May-26-20 07:17PM  
02:56PM  
May-24-20 09:04AM  
May-19-20 10:30AM  
May-14-20 06:42AM  
May-13-20 01:02PM  
10:16AM  
May-12-20 02:00PM  
11:06AM  
May-07-20 07:00PM  
02:15PM  
May-06-20 07:00PM  
12:15PM  
06:10AM  
May-05-20 10:00AM  
May-01-20 07:31PM  
06:29AM  
Apr-30-20 11:01PM  
03:21PM  
10:36AM  
07:28AM  
05:00AM  
Apr-29-20 05:45PM  
04:17PM  
04:05PM  
11:55AM  
11:54AM  
Apr-28-20 09:17AM  
Apr-27-20 02:05AM  
Apr-25-20 08:28AM  
Apr-24-20 09:29AM  
Apr-23-20 11:14PM  
07:10PM  
06:38AM  
Apr-22-20 12:31PM  
Apr-16-20 10:00AM  
Apr-15-20 01:09PM  
Apr-10-20 01:55PM  
Apr-08-20 05:50PM  
Apr-06-20 06:25PM  
Apr-05-20 08:00AM  
Apr-04-20 01:31PM  
Mar-31-20 02:00PM  
04:00AM  
Mar-30-20 11:00AM  
Mar-27-20 11:00AM  
Mar-25-20 01:30PM  
Mar-23-20 05:16AM  
Mar-16-20 09:24PM  
Mar-13-20 06:07AM  
Mar-11-20 12:47PM  
Mar-10-20 12:10PM  
Mar-09-20 09:15AM  
Feb-28-20 11:31AM  
Feb-27-20 11:24AM  
Feb-25-20 09:25AM  
Feb-22-20 07:02AM  
Feb-05-20 03:23PM  
Feb-04-20 09:20AM  
Feb-03-20 12:00PM  
09:23AM  
09:11AM  
Feb-01-20 07:08AM  
Jan-31-20 01:31PM  
Jan-30-20 10:04AM  
10:00AM  
07:00AM  
Jan-29-20 05:25PM  
04:49PM  
04:49PM  
04:26PM  
04:05PM  
02:27PM  
Jan-23-20 10:00AM  
Jan-22-20 12:31PM  
11:57AM  
10:00AM  
Jan-20-20 08:42AM  
Jan-16-20 05:18AM  
Jan-13-20 09:54AM  
Jan-12-20 08:11PM  
Jan-10-20 11:58AM  
Jan-09-20 05:00AM  
Jan-08-20 09:00AM  
Jan-07-20 09:30AM  
06:45AM  
Dec-30-19 09:15AM  
Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States and internationally. The company operates through three segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. It procures, stores, cleans, and transports agricultural raw materials, such as oilseeds, corn, wheat, milo, oats, rice, and barley. The company also engages in the agricultural commodity and feed product import, export, and distribution; and structured trade finance activities. In addition, it offers vegetable oils and protein meals; ingredients for the food, feed, energy, and industrial customers; crude vegetable oils, salad oils, margarine, shortening, and other food products; and partially refined oils to produce biodiesel and glycols for use in chemicals, paints, and other industrial products. Further, the company provides peanuts, tree nuts, peanut-derived ingredients, and cotton cellulose pulp; sweeteners, corn and wheat starches, syrup, glucose, wheat flour, dextrose, and bioproducts; alcohol and other food and animal feed ingredients; ethyl alcohol and ethanol; corn gluten feed and meal, as well as distillers' grains; and citric acids. Additionally, the company provides natural flavor ingredients, flavor systems, natural colors, proteins, emulsifiers, soluble fiber, polyols, hydrocolloids, and natural health and nutrition products, including probiotics, prebiotics, enzymes, and botanical extracts; and other specialty food and feed ingredients; edible beans; formula feeds, and animal health and nutrition products; and contract and private label pet treats and foods. It also engages in futures commission merchant and insurance services. The company has a partnership with Hospital de Sagunto. The company was founded in 1902 and is headquartered in Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cuddy Christopher MSenior Vice PresidentJun 05Option Exercise27.261,92952,593169,729Jun 08 12:20 PM
Cuddy Christopher MSenior Vice PresidentJun 05Sale42.761,92982,491167,800Jun 08 12:20 PM
Morris Gregory ASenior Vice PresidentJun 03Option Exercise30.713,11495,631187,444Jun 04 02:22 PM
Morris Gregory ASenior Vice PresidentJun 03Sale40.003,114124,560184,330Jun 04 02:22 PM
Dufour PierreDirectorMay 12Buy35.201,07037,6641,070May 13 11:32 AM
Sanchez Francisco JDirectorMar 06Buy36.951,37050,6224,370Mar 06 04:26 PM
D AMBROSE MICHAELSenior Vice PresidentFeb 06Option Exercise27.266,635180,902211,696Feb 07 10:57 AM
D AMBROSE MICHAELSenior Vice PresidentFeb 06Sale46.136,635306,086205,061Feb 07 10:57 AM
D AMBROSE MICHAELSenior Vice PresidentFeb 05Sale46.0011,500529,043205,061Feb 06 11:28 AM
Sanchez Francisco JDirectorJan 02Option Exercise0.001,38304,383Jan 06 10:38 AM
WESTBROOK KELVIN RDirectorJan 02Option Exercise0.004,19604,196Jan 06 10:38 AM
Dufour PierreDirectorJan 02Option Exercise0.003,500011,200Jan 06 10:37 AM
Taets Joseph D.Senior Vice PresidentDec 17Option Exercise27.3925,503698,633216,014Dec 18 02:35 PM
Taets Joseph D.Senior Vice PresidentDec 17Sale47.0025,5031,198,641190,511Dec 18 02:35 PM
Stott John PGroup VP, Finance & ControllerDec 16Option Exercise30.716,673204,92838,874Dec 17 05:25 PM
Stott John PGroup VP, Finance & ControllerDec 16Sale46.006,673306,95832,201Dec 17 05:25 PM
Stott John PGroup VP, Finance & ControllerNov 14Sale42.662,500106,64032,201Nov 15 12:35 PM
LUCIANO JUAN RPresident & CEOAug 06Buy36.655,457199,990109,453Aug 06 05:30 PM
Young Ray GChief Financial OfficerAug 06Buy36.743,400124,899353,181Aug 06 01:39 PM
T AT&T Inc. daily Stock Chart
T [NYSE]
AT&T Inc.
IndexS&P 500 P/E15.47 EPS (ttm)1.97 Insider Own0.08% Shs Outstand7.19B Perf Week4.85%
Market Cap215.94B Forward P/E9.23 EPS next Y3.31 Insider Trans2.55% Shs Float7.12B Perf Month-4.12%
Income14.38B PEG8.73 EPS next Q0.79 Inst Own56.50% Short Float1.69% Perf Quarter11.03%
Sales179.15B P/S1.21 EPS this Y-30.90% Inst Trans-2.42% Short Ratio3.12 Perf Half Y-21.94%
Book/sh24.74 P/B1.23 EPS next Y3.61% ROA2.60% Target Price33.64 Perf Year-11.11%
Cash/sh1.41 P/C21.69 EPS next 5Y1.77% ROE7.90% 52W Range26.08 - 39.70 Perf YTD-21.98%
Dividend2.08 P/FCF17.53 EPS past 5Y8.90% ROI7.00% 52W High-23.20% Beta0.68
Dividend %6.82% Quick Ratio0.80 Sales past 5Y6.50% Gross Margin53.80% 52W Low16.91% ATR0.73
Employees244000 Current Ratio0.80 Sales Q/Q-4.60% Oper. Margin15.70% RSI (14)52.48 Volatility1.84% 2.26%
OptionableYes Debt/Eq0.92 EPS Q/Q13.70% Profit Margin8.00% Rel Volume0.87 Prev Close30.08
ShortableYes LT Debt/Eq0.83 EarningsJul 23 BMO Payout103.70% Avg Volume38.62M Price30.49
Recom2.70 SMA20-0.41% SMA500.82% SMA200-12.71% Volume33,630,573 Change1.36%
Apr-24-20Downgrade DZ Bank Hold → Sell $26
Apr-01-20Downgrade JP Morgan Overweight → Neutral $38 → $35
Mar-23-20Downgrade Robert W. Baird Outperform → Neutral $41 → $33
Mar-23-20Downgrade Cowen Outperform → Market Perform $43 → $37
Mar-16-20Downgrade Raymond James Outperform → Mkt Perform
Jan-30-20Downgrade UBS Buy → Neutral $42 → $39
Jan-22-20Initiated Deutsche Bank Buy $44
Nov-19-19Downgrade MoffettNathanson Neutral → Sell $30
Nov-14-19Downgrade HSBC Securities Buy → Hold $42
Nov-01-19Downgrade Standpoint Research Buy → Hold
Oct-16-19Initiated Bernstein Mkt Perform
Jul-25-19Upgrade Credit Suisse Underperform → Neutral $29
Mar-15-19Upgrade Raymond James Mkt Perform → Outperform $34
Dec-11-18Upgrade Citigroup Neutral → Buy
Dec-03-18Upgrade JP Morgan Neutral → Overweight
Nov-26-18Upgrade MoffettNathanson Sell → Neutral
Oct-22-18Upgrade Tigress Financial Neutral → Buy
Sep-24-18Reiterated Deutsche Bank Hold $35 → $37
Aug-22-18Downgrade Wells Fargo Outperform → Market Perform
Jul-30-18Upgrade BofA/Merrill Neutral → Buy
Jul-06-20 03:43PM  
03:07PM  
10:30AM  
06:00AM  
Jul-05-20 10:51PM  
12:35PM  
Jul-04-20 05:51AM  
Jul-03-20 10:15AM  
07:00AM  
Jul-02-20 11:18AM  
09:27AM  
06:06AM  
Jul-01-20 01:54PM  
12:45PM  
10:57AM  
09:00AM  
08:27AM  
Jun-30-20 07:25PM  
12:59PM  
10:54AM  
08:52AM  
08:49AM  
08:44AM  
Jun-29-20 08:22PM  
04:53PM  
02:57PM  
02:12PM  
10:43AM  
09:30AM  
08:00AM  
Jun-28-20 02:54PM  
12:26PM  
11:13AM  
Jun-27-20 09:34AM  
Jun-26-20 04:03PM  
03:11PM  
03:10PM  
01:04PM  
12:44PM  
10:41AM  
Jun-25-20 06:10PM  
01:23PM  
11:27AM  
Jun-24-20 05:13PM  
04:21PM  
01:30PM  
11:42AM  
01:59AM  
Jun-23-20 07:02PM  
06:54PM  
03:46PM  
01:14PM  
12:19PM  
11:00AM  
09:30AM  
09:30AM  
Jun-22-20 07:25PM  
08:42AM  
Jun-21-20 11:41AM  
08:00AM  
Jun-20-20 01:59PM  
09:17AM  
Jun-19-20 08:42PM  
10:29AM  
09:11AM  
08:57AM  
Jun-18-20 04:21PM  
04:00PM  
02:24PM  
02:19PM  
01:31PM  
11:55AM  
10:33AM  
10:03AM  
09:39AM  
09:21AM  
Jun-17-20 06:42PM  
06:21PM  
02:43PM  
12:50PM  
12:25PM  
08:33AM  
12:59AM  
Jun-16-20 08:02PM  
07:18PM  
05:05PM  
04:44PM  
02:49PM  
02:39PM  
01:35PM  
12:27PM  
09:10AM  
08:15AM  
05:51AM  
Jun-15-20 06:54PM  
05:10PM  
02:58PM  
01:44PM  
01:34PM  
01:07PM  
AT&T Inc. provides telecommunication, media, and technology services worldwide. The company operates through four segments: Communications, WarnerMedia, Latin America, and Xandr. The Communications segment provides wireless and wireline telecom, video, and broadband and Internet services; video entertainment services using satellite, IP-based, and streaming options; and audio programming services under the AT&T, Cricket, AT&T PREPAID, and DIRECTV brands to residential and business customers. This segment also sells handsets, wirelessly enabled computers, and wireless data cards manufactured by various suppliers for use with company's voice and data services, as well as various accessories, such as carrying cases and hands-free devices through the company-owned stores, agents, and third-party retail stores. The WarnerMedia segment primarily produces, distributes, and licenses television programming and feature films; distributes home entertainment products in physical and digital formats; and produces and distributes mobile and console games, and consumer products, as well as offers brand licensing services. It also operates cable networks, multichannel premium pay television, and over-the-top services; and digital media properties. The Latin America segment offers video entertainment and audio programming services under the DIRECTV and SKY brands primarily to residential customers; pay-TV services, including HD sports video content; and postpaid and prepaid wireless services under the AT&T and Unefon brands, as well as sells various handsets through company-owned stores, agents, and third-party retail stores. The Xandr segment provides digital and video advertising services. The company was formerly known as SBC Communications Inc. and changed its name to AT&T Inc. in November 2005. AT&T Inc. was incorporated in 1983 and is based in Dallas, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STEPHENS JOHN JOSEPHSr. Exec. VP and CFOJun 03Option Exercise25.5438,069972,282556,092Jun 04 06:11 PM
STEPHENSON RANDALL LChairman and CEOMay 29Option Exercise25.54379,3369,688,2411,749,086Jun 02 05:57 PM
YANG GEOFFREY YDirectorApr 24Buy29.396,754198,46677,011Apr 27 05:53 PM
LUCZO STEPHEN JDirectorApr 22Buy29.3836,0001,057,579200,000Apr 23 06:19 PM
STEPHENS JOHN JOSEPHSr. Exec. VP and CFOFeb 10Option Exercise25.328,454214,055516,146Feb 12 02:51 PM
LUCZO STEPHEN JDirectorFeb 04Buy37.60100,0003,760,380164,000Feb 05 05:28 PM
Lee Lori MCEO-AT&T LatAm&GlobalMktgOfcrAug 07Option Exercise26.452,10455,660978Aug 08 01:32 PM
STANKEY JOHN TCEO, Warner Media, LLCJul 30Option Exercise25.414,024102,2524,024Jul 30 05:56 PM
STANKEY JOHN TCEO, Warner Media, LLCJul 30Sale34.154,024137,4200Jul 30 05:56 PM
ADP Automatic Data Processing, Inc. daily Stock Chart
ADP [NASD]
Automatic Data Processing, Inc.
IndexS&P 500 P/E25.84 EPS (ttm)5.83 Insider Own0.10% Shs Outstand430.00M Perf Week4.15%
Market Cap64.16B Forward P/E26.41 EPS next Y5.71 Insider Trans-9.00% Shs Float429.00M Perf Month0.51%
Income2.53B PEG2.12 EPS next Q0.96 Inst Own82.30% Short Float0.99% Perf Quarter17.24%
Sales14.71B P/S4.36 EPS this Y12.30% Inst Trans0.05% Short Ratio1.84 Perf Half Y-11.31%
Book/sh12.77 P/B11.80 EPS next Y-0.54% ROA5.90% Target Price156.07 Perf Year-8.56%
Cash/sh4.01 P/C37.56 EPS next 5Y12.20% ROE46.80% 52W Range103.11 - 182.32 Perf YTD-11.60%
Dividend3.64 P/FCF46.54 EPS past 5Y15.30% ROI31.10% 52W High-17.33% Beta0.83
Dividend %2.41% Quick Ratio1.00 Sales past 5Y6.70% Gross Margin42.90% 52W Low46.18% ATR4.07
Employees58000 Current Ratio1.00 Sales Q/Q5.70% Oper. Margin21.90% RSI (14)53.23 Volatility1.74% 2.86%
OptionableYes Debt/Eq0.37 EPS Q/Q10.10% Profit Margin17.20% Rel Volume0.64 Prev Close150.54
ShortableYes LT Debt/Eq0.18 EarningsJul 29 BMO Payout56.00% Avg Volume2.31M Price150.73
Recom2.70 SMA200.21% SMA503.75% SMA200-3.85% Volume1,470,490 Change0.13%
May-18-20Downgrade BofA/Merrill Neutral → Underperform
Jan-22-20Upgrade Evercore ISI In-line → Outperform $212
Jan-14-20Resumed Citigroup Neutral $185
Jan-07-20Downgrade MoffettNathanson Buy → Neutral
Oct-31-19Downgrade Wolfe Research Outperform → Peer Perform
Sep-11-19Initiated Cowen Outperform $195
Sep-11-19Downgrade BofA/Merrill Buy → Neutral
Apr-30-19Downgrade Bernstein Outperform → Mkt Perform
Oct-04-18Initiated MoffettNathanson Buy $180
Aug-10-18Initiated Credit Suisse Outperform $160
Apr-02-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Feb-01-18Reiterated Stifel Hold $113 → $133
Jan-12-18Reiterated Citigroup Neutral $110 → $118
Dec-11-17Upgrade Goldman Neutral → Buy
Dec-05-17Upgrade BofA/Merrill Neutral → Buy
Nov-14-17Upgrade Morgan Stanley Underweight → Equal-Weight
Nov-06-17Reiterated RBC Capital Mkts Sector Perform $95 → $100
Aug-03-17Downgrade Morgan Stanley Equal-Weight → Underweight
Aug-01-17Reiterated RBC Capital Mkts Sector Perform $94 → $95
Jul-31-17Upgrade Evercore ISI Underperform → In-line
Jul-01-20 08:15AM  
Jun-26-20 04:30AM  
Jun-24-20 08:15AM  
Jun-18-20 08:30AM  
Jun-15-20 08:00AM  
Jun-11-20 08:30AM  
Jun-08-20 12:15PM  
10:35AM  
Jun-03-20 12:31PM  
10:15AM  
09:32AM  
08:23AM  
08:15AM  
07:36AM  
Jun-01-20 02:49PM  
09:50AM  
May-31-20 05:42PM  
May-29-20 12:47PM  
12:24PM  
11:31AM  
May-27-20 10:32AM  
08:15AM  
May-23-20 08:43AM  
May-22-20 10:26AM  
May-21-20 08:30AM  
May-18-20 10:32AM  
May-14-20 08:58AM  
08:30AM  
May-13-20 06:37PM  
03:35PM  
10:41AM  
May-12-20 05:24AM  
May-09-20 07:00PM  
May-08-20 12:45PM  
May-07-20 04:56PM  
12:29PM  
May-06-20 04:11PM  
01:57PM  
09:38AM  
08:15AM  
05:04AM  
May-05-20 02:24PM  
07:12AM  
May-03-20 08:25PM  
08:10AM  
May-01-20 10:43PM  
Apr-30-20 11:40AM  
Apr-29-20 11:39AM  
09:35AM  
08:15AM  
07:00AM  
Apr-28-20 09:04AM  
Apr-27-20 01:02PM  
Apr-22-20 12:31PM  
Apr-16-20 08:30AM  
Apr-14-20 11:40AM  
Apr-10-20 06:38AM  
Apr-09-20 01:59PM  
08:30AM  
Apr-08-20 02:45PM  
02:24PM  
Apr-03-20 09:05AM  
Apr-02-20 04:31AM  
Apr-01-20 02:13PM  
09:32AM  
08:15AM  
04:20AM  
04:17AM  
Mar-31-20 02:07PM  
Mar-25-20 08:00PM  
08:15AM  
Mar-23-20 08:00PM  
11:40AM  
07:59AM  
Mar-19-20 08:30AM  
Mar-17-20 06:15AM  
Mar-16-20 04:15PM  
Mar-12-20 04:06PM  
08:30AM  
Mar-11-20 09:28PM  
Mar-09-20 06:21PM  
Mar-05-20 02:04PM  
Mar-04-20 11:40AM  
08:15AM  
04:52AM  
Mar-03-20 03:30PM  
12:39PM  
Feb-28-20 11:31AM  
Feb-26-20 08:15AM  
Feb-24-20 03:15PM  
Feb-22-20 12:03PM  
Feb-21-20 05:20AM  
Feb-20-20 08:30AM  
Feb-19-20 10:26AM  
Feb-13-20 08:30AM  
Feb-10-20 07:00PM  
10:51AM  
Feb-07-20 11:04AM  
10:56AM  
04:38AM  
Automatic Data Processing, Inc. provides cloud-based human capital management solutions worldwide. It operates through two segments, Employer Services and Professional Employer Organization (PEO) Services. The Employer Services segment offers strategic, cloud-based platforms, and human resources (HR) outsourcing solutions. Its offerings include payroll, benefits administration, talent management, HR management, workforce management, insurance, retirement, and compliance services. The PEO Services segment provides HR outsourcing solutions through a co-employment model. This segment offers protection and compliance, talent engagement, comprehensive outsourcing, and recruitment process outsourcing services. The company was founded in 1949 and is headquartered in Roseland, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Michaud Brian L.Corp VPApr 13Sale140.2325035,0585,412Apr 14 12:28 PM
Weinstein DonaldCorporate VPFeb 06Option Exercise86.612,468213,75326,578Feb 07 09:55 AM
Eberhard Michael CCorporate Vice PresidentFeb 06Option Exercise75.1013,5631,018,58153,564Feb 07 09:55 AM
Eberhard Michael CCorporate Vice PresidentFeb 06Sale180.0013,5632,441,34040,001Feb 07 09:55 AM
Weinstein DonaldCorporate VPFeb 06Sale180.002,468444,24024,110Feb 07 09:55 AM
Dyson Deborah LCorp. VPFeb 04Sale176.673,250574,17818,304Feb 05 10:56 AM
Ayala JohnCorp. VPJan 17Option Exercise146.756,484951,52719,578Jan 21 09:18 AM
Ayala JohnCorp. VPJan 17Sale176.036,4841,141,37913,094Jan 21 09:18 AM
McGuire DonCorp VPJan 15Sale172.0732656,0956,917Jan 16 11:55 AM
Dyson Deborah LCorp. VPJan 03Sale168.063,250546,19521,554Jan 06 11:00 AM
Perrotti Thomas JCorp. VPJan 03Sale169.7312,5022,122,01117,088Jan 06 11:01 AM
Eberhard Michael CCorporate Vice PresidentJan 02Option Exercise79.2422,1511,755,16062,152Jan 03 11:41 AM
Bonarti Michael ACorporate Vice PresidentJan 02Option Exercise75.104,417331,71749,634Jan 03 11:41 AM
Albinson BrockCorp. VPJan 02Option Exercise146.751,832268,8466,861Jan 03 11:41 AM
Politi Douglas WCorp. VPJan 02Option Exercise82.6127,5262,273,84454,739Jan 03 11:41 AM
O'Brien Dermot JCorp. VPJan 02Sale170.111,500255,16213,474Jan 03 11:41 AM
Politi Douglas WCorp. VPJan 02Sale170.0931,6765,387,77423,119Jan 03 11:41 AM
Weinstein DonaldCorporate VPJan 02Sale170.082,000340,16824,110Jan 03 11:41 AM
Albinson BrockCorp. VPJan 02Sale170.073,156536,7263,705Jan 03 11:41 AM
Bonarti Michael ACorporate Vice PresidentJan 02Sale170.094,417751,29145,217Jan 03 11:41 AM
Eberhard Michael CCorporate Vice PresidentJan 02Sale170.1822,1513,769,67140,001Jan 03 11:41 AM
Rodriguez Carlos APresident & CEONov 14Option Exercise107.3548,5715,214,097144,899Nov 15 04:56 PM
Rodriguez Carlos APresident & CEONov 14Sale169.4348,5718,229,56296,328Nov 15 04:56 PM
Rodriguez Carlos APresident & CEONov 13Option Exercise107.3548,5715,214,097144,899Nov 15 04:56 PM
Rodriguez Carlos APresident & CEONov 13Sale168.5148,5718,184,61596,328Nov 15 04:56 PM
Rodriguez Carlos APresident & CEOSep 12Option Exercise90.6352,2284,733,424148,556Sep 16 04:52 PM
Rodriguez Carlos APresident & CEOSep 12Sale160.9252,2288,404,56896,328Sep 16 04:52 PM
Rodriguez Carlos APresident & CEOSep 11Option Exercise75.1049,3923,709,339145,720Sep 12 05:03 PM
Rodriguez Carlos APresident & CEOSep 11Sale161.7049,3927,986,51096,328Sep 12 05:03 PM
Rodriguez Carlos APresident & CEOSep 10Sale163.4336,1105,901,40496,328Sep 12 05:03 PM
Bonarti Michael ACorporate Vice PresidentSep 03Option Exercise77.6016,9221,313,10766,371Sep 04 04:43 PM
Black MariaCorp. VPSep 03Option Exercise84.126,522548,59931,893Sep 04 04:43 PM
Ayala JohnCorp. VPSep 03Option Exercise94.3914,2151,341,80136,222Sep 04 04:43 PM
Albinson BrockCorp. VPSep 03Option Exercise91.855,410496,89011,712Sep 04 04:43 PM
Perrotti Thomas JCorp. VPSep 03Option Exercise99.4119,6401,952,45247,227Sep 04 04:44 PM
O'Brien Dermot JCorp. VPSep 03Option Exercise93.8718,6591,751,44740,648Sep 04 04:44 PM
O'Brien Dermot JCorp. VPSep 03Sale168.0525,7514,327,49614,897Sep 04 04:44 PM
Perrotti Thomas JCorp. VPSep 03Sale167.8717,6372,960,76829,590Sep 04 04:44 PM
Albinson BrockCorp. VPSep 03Sale167.876,6831,121,8875,029Sep 04 04:43 PM
Ayala JohnCorp. VPSep 03Sale168.0423,1283,886,50913,094Sep 04 04:43 PM
Black MariaCorp. VPSep 03Sale168.0114,5412,443,09717,352Sep 04 04:43 PM
Bonarti Michael ACorporate Vice PresidentSep 03Sale167.7921,1543,549,48845,217Sep 04 04:43 PM
Sackman StuartCorp. VPSep 03Sale168.027,7561,303,13922,644Sep 04 04:44 PM
Weinstein DonaldCorporate VPSep 03Sale167.6347579,62626,110Sep 04 04:44 PM
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E80.69 EPS (ttm)3.10 Insider Own0.20% Shs Outstand272.01M Perf Week7.24%
Market Cap71.54B Forward P/E20.07 EPS next Y12.48 Insider Trans-17.17% Shs Float271.07M Perf Month2.84%
Income853.00M PEG16.14 EPS next Q2.09 Inst Own83.60% Short Float0.79% Perf Quarter10.47%
Sales17.41B P/S4.11 EPS this Y24.40% Inst Trans1.25% Short Ratio0.99 Perf Half Y-7.09%
Book/sh77.01 P/B3.25 EPS next Y19.84% ROA1.80% Target Price274.43 Perf Year-1.47%
Cash/sh8.25 P/C30.35 EPS next 5Y5.00% ROE4.40% 52W Range197.75 - 286.72 Perf YTD-7.91%
Dividend3.16 P/FCF38.14 EPS past 5Y-8.90% ROI4.30% 52W High-12.64% Beta0.93
Dividend %1.26% Quick Ratio0.70 Sales past 5Y15.40% Gross Margin46.50% 52W Low26.66% ATR6.61
Employees70093 Current Ratio1.00 Sales Q/Q1.40% Oper. Margin9.20% RSI (14)60.51 Volatility2.66% 2.68%
OptionableYes Debt/Eq1.01 EPS Q/Q390.40% Profit Margin5.30% Rel Volume1.47 Prev Close245.03
ShortableYes LT Debt/Eq0.80 EarningsAug 06 BMO Payout91.50% Avg Volume2.17M Price250.47
Recom2.10 SMA205.83% SMA501.55% SMA200-0.56% Volume3,188,152 Change2.22%
Jun-01-20Resumed Goldman Buy $278
Mar-05-20Initiated Citigroup Neutral $260
Feb-07-20Downgrade Raymond James Strong Buy → Outperform $283
Feb-07-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-07-20Downgrade Cowen Outperform → Market Perform
Feb-06-20Downgrade Cowen Outperform → Market Perform
Jan-08-20Downgrade Barclays Overweight → Equal Weight $275
May-13-19Upgrade Barclays Equal Weight → Overweight $266
Dec-07-18Initiated Deutsche Bank Buy $280
Oct-16-18Initiated Barclays Equal Weight $278
Jun-21-18Upgrade JP Morgan Neutral → Overweight
Apr-10-18Upgrade Citigroup Neutral → Buy
Jan-19-18Resumed BofA/Merrill Buy $260
Jan-05-18Upgrade Citigroup Sell → Neutral
Jan-05-18Initiated KeyBanc Capital Mkts Overweight
Jan-03-18Initiated Evercore ISI Outperform
Dec-29-17Reiterated Deutsche Bank Buy $239 → $260
Nov-03-17Reiterated RBC Capital Mkts Sector Perform $210 → $230
Sep-22-17Initiated Wells Fargo Outperform $225
Jun-30-17Upgrade Raymond James Outperform → Strong Buy
Jul-06-20 04:39PM  
04:15PM  
04:03PM  
03:39PM  
10:53AM  
07:43AM  
07:07AM  
07:00AM  
06:59AM  
Jul-03-20 03:00AM  
Jul-02-20 04:10PM  
Jun-19-20 09:47AM  
Jun-06-20 11:31AM  
Jun-04-20 03:20PM  
Jun-01-20 05:00PM  
May-27-20 06:11PM  
01:25PM  
12:56PM  
08:00AM  
May-26-20 04:15PM  
06:11AM  
May-21-20 02:06AM  
May-20-20 03:33PM  
May-19-20 04:05PM  
May-18-20 04:20PM  
01:38PM  
May-16-20 09:15AM  
May-15-20 06:40AM  
May-14-20 06:43AM  
May-13-20 06:23AM  
May-11-20 10:34AM  
May-10-20 12:43PM  
May-07-20 10:30PM  
11:20AM  
09:09AM  
07:35AM  
May-06-20 09:07AM  
May-04-20 11:02AM  
09:03AM  
May-03-20 08:26PM  
Apr-30-20 06:45PM  
12:34PM  
Apr-29-20 07:10AM  
06:40AM  
Apr-28-20 07:00AM  
Apr-27-20 12:55PM  
11:45AM  
10:57AM  
10:33AM  
09:30AM  
09:00AM  
08:28AM  
Apr-26-20 10:50PM  
02:45PM  
01:45PM  
01:00PM  
11:15AM  
Apr-25-20 02:45PM  
01:00PM  
11:04AM  
Apr-24-20 10:50PM  
08:05PM  
05:45PM  
05:10PM  
03:22PM  
01:15PM  
12:31PM  
11:44AM  
11:30AM  
11:00AM  
10:56AM  
10:18AM  
02:55AM  
Apr-23-20 06:00PM  
02:01PM  
12:30PM  
12:00PM  
11:00AM  
10:57AM  
09:34AM  
Apr-22-20 10:50PM  
08:44PM  
04:55PM  
04:10PM  
02:20PM  
12:36PM  
10:45AM  
10:00AM  
09:05AM  
Apr-21-20 10:50PM  
05:55PM  
03:55PM  
03:55PM  
10:45AM  
Apr-20-20 10:50PM  
11:00AM  
10:00AM  
Apr-19-20 11:00AM  
07:00AM  
Apr-17-20 10:50PM  
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaltenbach PatrickEVP & Pres Life SciencesJun 05Sale243.201,049255,11711,612Jun 05 03:07 PM
Kaltenbach PatrickEVP & Pres Life SciencesJun 02Sale244.8322254,35214,688Jun 02 02:24 PM
Fraser ClaireDirectorMay 08Sale256.56771197,80820,168May 08 02:29 PM
Khichi Samrat S.EVP and General CounselMar 16Sale224.534,349976,4815,262Mar 17 01:03 PM
Fraser ClaireDirectorFeb 11Sale258.721,500388,07420,939Feb 11 03:17 PM
Campion Simon DEVP and Segment PresidentFeb 04Option Exercise115.6813,6121,574,62115,556Feb 05 02:48 PM
Campion Simon DEVP and Segment PresidentFeb 04Sale285.098,0852,304,95310,773Feb 05 02:48 PM
Mas Ribo AlbertoEVP and Pres, Life SciencesFeb 04Sale285.001,430407,5508,381Feb 05 09:13 AM
FORLENZA VINCENT AChairman, CEO and PresidentJan 28Option Exercise72.1238,3622,766,667247,226Jan 28 05:05 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 28Sale280.9628,5148,011,293208,864Jan 28 05:05 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 27Option Exercise72.1234,4062,481,361243,270Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 27Sale280.0925,5467,155,179208,864Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 24Option Exercise72.129,666697,112218,530Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 24Sale280.137,1772,010,493208,864Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 23Option Exercise72.128,464610,424217,328Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 23Sale280.066,2841,759,897208,864Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 10Option Exercise72.1226,6651,923,080235,529Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 10Sale275.1519,6755,413,576208,864Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 08Option Exercise72.1218,7831,354,630227,647Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 08Sale275.1913,8603,814,133208,864Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 02Option Exercise72.1245,4483,277,710254,312Jan 03 09:08 AM
FORLENZA VINCENT AChairman, CEO and PresidentJan 02Sale271.2833,3659,051,257208,864Jan 03 09:08 AM
Polen Thomas E JrExecutive Vice PresidentDec 16Option Exercise145.8013,9072,027,59027,117Dec 17 11:39 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesDec 16Option Exercise134.7312,1531,637,37427,739Dec 18 09:45 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesDec 16Sale269.5111,8603,196,3899,811Dec 18 09:45 AM
Polen Thomas E JrExecutive Vice PresidentDec 16Sale269.636,3861,721,85717,117Dec 17 11:39 AM
Spoerel Thomas JVP Controller & Chief Acct OffDec 13Sale267.95506135,5831,035Dec 16 09:10 AM
FORLENZA VINCENT AChairman, CEO and PresidentDec 12Option Exercise76.6416,3431,252,528225,393Dec 16 09:15 AM
Kaltenbach PatrickEVP & Pres Life SciencesDec 12Option Exercise242.104,2361,025,53619,546Dec 16 09:17 AM
Kaltenbach PatrickEVP & Pres Life SciencesDec 12Sale263.2333989,23515,310Dec 16 09:17 AM
FORLENZA VINCENT AChairman, CEO and PresidentDec 12Sale265.5711,6263,087,517209,050Dec 16 09:15 AM
Kaltenbach PatrickEVP & Pres Life SciencesDec 06Sale261.5131281,59115,310Dec 06 04:11 PM
Bodner Charles RSVP Corp Fin Chief Acct OfficeSep 06Option Exercise134.733,143423,4565,180Sep 09 01:19 PM
Polen Thomas E JrExecutive Vice PresidentSep 06Option Exercise150.1213,7602,065,65130,215Sep 09 01:50 PM
Lim James CExecutive Vice PresidentSep 06Option Exercise108.8915,8481,725,68933,041Sep 09 10:55 AM
FORLENZA VINCENT AChairman, CEO and PresidentSep 06Option Exercise76.6416,3431,252,528237,431Sep 10 10:50 AM
FORLENZA VINCENT AChairman, CEO and PresidentSep 06Sale260.3811,5323,002,702221,088Sep 10 10:50 AM
Lim James CExecutive Vice PresidentSep 06Sale263.539,2992,450,56517,193Sep 09 10:55 AM
Polen Thomas E JrExecutive Vice PresidentSep 06Sale260.265,8231,515,49416,455Sep 09 01:50 PM
Bodner Charles RSVP Corp Fin Chief Acct OfficeSep 06Sale260.081,514393,7612,037Sep 09 01:19 PM
Conroy AlexandreEVP of Integrated Supply ChainAug 30Sale256.724611,80916,489Sep 03 09:47 AM
Conroy AlexandreEVP of Integrated Supply ChainAug 29Sale255.069,8292,506,98516,535Aug 29 04:39 PM
Lim James CExecutive Vice PresidentAug 09Option Exercise75.2133,9662,554,73139,902Aug 12 11:21 AM
Lim James CExecutive Vice PresidentAug 09Sale253.3123,8796,048,78917,193Aug 12 11:21 AM
Kaltenbach PatrickEVP & Pres Life SciencesAug 09Sale253.7812732,23015,930Aug 12 09:57 AM
Goette RolandEVP and President, EMEAAug 08Option Exercise75.632,463186,2778,710Aug 09 10:49 AM
Kaltenbach PatrickEVP & Pres Life SciencesAug 08Option Exercise224.942,865644,45319,072Aug 09 11:11 AM
Lim James CExecutive Vice PresidentAug 08Option Exercise76.642,773212,52319,966Aug 09 10:09 AM
Lim James CExecutive Vice PresidentAug 08Sale252.011,929486,12717,193Aug 09 10:09 AM
Kaltenbach PatrickEVP & Pres Life SciencesAug 08Sale246.5540098,62016,057Aug 09 11:11 AM
Goette RolandEVP and President, EMEAAug 08Sale249.881,717429,0446,247Aug 09 10:49 AM
Fraser ClaireDirectorAug 07Sale243.261,429347,61921,544Aug 07 02:56 PM
BF-B Brown-Forman Corporation daily Stock Chart
BF-B [NYSE]
Brown-Forman Corporation
IndexS&P 500 P/E37.61 EPS (ttm)1.72 Insider Own0.40% Shs Outstand478.13M Perf Week6.10%
Market Cap30.07B Forward P/E34.83 EPS next Y1.86 Insider Trans0.00% Shs Float345.12M Perf Month-1.04%
Income827.00M PEG- EPS next Q0.32 Inst Own52.20% Short Float2.45% Perf Quarter16.74%
Sales3.36B P/S8.94 EPS this Y15.90% Inst Trans0.24% Short Ratio8.07 Perf Half Y-3.89%
Book/sh4.13 P/B15.67 EPS next Y13.09% ROA14.90% Target Price61.53 Perf Year13.23%
Cash/sh1.45 P/C44.54 EPS next 5Y-0.60% ROE43.60% 52W Range44.68 - 72.85 Perf YTD-4.26%
Dividend0.70 P/FCF105.12 EPS past 5Y6.00% ROI19.90% 52W High-11.16% Beta0.76
Dividend %1.08% Quick Ratio1.80 Sales past 5Y1.40% Gross Margin63.20% 52W Low44.85% ATR1.95
Employees4800 Current Ratio3.70 Sales Q/Q-4.70% Oper. Margin32.40% RSI (14)49.26 Volatility2.21% 3.29%
OptionableYes Debt/Eq1.32 EPS Q/Q-4.50% Profit Margin24.60% Rel Volume0.48 Prev Close64.43
ShortableYes LT Debt/Eq1.15 EarningsJun 09 BMO Payout39.30% Avg Volume1.05M Price64.72
Recom3.20 SMA20-1.17% SMA50-0.49% SMA2000.66% Volume505,695 Change0.45%
Apr-01-20Resumed Goldman Sell $54
Mar-09-20Downgrade Morgan Stanley Equal-Weight → Underweight $62 → $57
Nov-15-19Downgrade CFRA Hold → Sell
Sep-20-19Initiated MKM Partners Neutral
Sep-19-19Downgrade Evercore ISI In-line → Underperform $60
Jan-09-19Downgrade Goldman Neutral → Sell
Dec-13-18Initiated UBS Neutral $48
Sep-07-18Initiated Jefferies Hold
Jun-28-18Upgrade Morgan Stanley Underweight → Equal-Weight
Jun-12-18Downgrade Societe Generale Hold → Sell
Mar-07-18Upgrade Pivotal Research Group Hold → Buy $52 → $65
Jan-10-18Initiated Barclays Equal Weight $72
Dec-07-17Upgrade Societe Generale Sell → Hold
Dec-07-17Reiterated Stifel Hold $49 → $69
Dec-07-17Downgrade Pivotal Research Group Buy → Hold $62 → $65
Sep-28-17Upgrade Goldman Sell → Neutral
Jun-08-17Downgrade Societe Generale Hold → Sell
Jun-08-17Downgrade Credit Suisse Outperform → Neutral
May-24-17Downgrade Citigroup Buy → Neutral
Mar-08-17Reiterated Stifel Hold $42 → $45
Jul-04-20 04:12AM  
Jul-03-20 07:12AM  
Jul-01-20 07:30AM  
Jun-16-20 10:02AM  
09:50AM  
Jun-15-20 01:00PM  
10:58AM  
10:51AM  
08:45AM  
Jun-11-20 08:41AM  
Jun-10-20 10:53AM  
08:00AM  
05:42AM  
Jun-09-20 03:08PM  
02:22PM  
11:28AM  
10:39AM  
10:27AM  
10:27AM  
08:24AM  
08:00AM  
Jun-08-20 12:37PM  
Jun-07-20 03:00PM  
Jun-03-20 08:18PM  
09:21AM  
May-27-20 10:57AM  
May-22-20 10:46AM  
May-21-20 05:05PM  
03:13PM  
May-08-20 10:00PM  
10:38AM  
May-07-20 01:49PM  
Apr-30-20 02:05PM  
Apr-03-20 11:30AM  
Mar-27-20 11:32AM  
Mar-23-20 08:29AM  
Mar-20-20 11:40AM  
Mar-18-20 02:45PM  
Mar-17-20 02:51PM  
Mar-16-20 10:35AM  
Mar-15-20 03:22PM  
Mar-13-20 03:01PM  
Mar-04-20 12:31PM  
12:07PM  
11:24AM  
10:03AM  
09:05AM  
07:59AM  
07:45AM  
Mar-02-20 02:27PM  
09:47AM  
Mar-01-20 07:11AM  
Feb-27-20 09:14AM  
07:31AM  
04:30AM  
Feb-26-20 12:30PM  
Feb-18-20 10:43AM  
Feb-17-20 06:08AM  
Feb-13-20 04:23PM  
10:44AM  
Feb-07-20 12:45PM  
11:04AM  
Feb-03-20 12:14PM  
Jan-28-20 04:15PM  
02:52PM  
Jan-27-20 06:00PM  
Jan-24-20 09:22AM  
Jan-23-20 12:41PM  
11:43AM  
Jan-22-20 06:53AM  
Jan-21-20 12:36PM  
Jan-18-20 07:19AM  
Jan-04-20 11:30AM  
Jan-03-20 09:07AM  
Jan-02-20 10:58AM  
Dec-30-19 10:37AM  
Dec-23-19 03:02PM  
Dec-19-19 07:07AM  
Dec-13-19 02:18PM  
Dec-10-19 11:56AM  
Dec-09-19 04:59PM  
Dec-05-19 03:09PM  
12:56PM  
10:32AM  
09:05AM  
08:08AM  
07:51AM  
Dec-04-19 06:55AM  
Nov-30-19 10:59AM  
Nov-28-19 10:30AM  
Nov-27-19 01:48PM  
06:20AM